ADA Scientific Sessions 2026 Abstract

Significant Synergistic Effects in Diabetic Kidney Disease by HDM1010

By Rongyao Zhu, Zhenzhen Li, Hao Pan, Chunhua Jiang, Dongzhou Liu

Experiments in animalsInterventions

The paper

Rongyao Zhu, Zhenzhen Li, Hao Pan, Chunhua Jiang, Dongzhou Liu

Hangzhou

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1373-P

doi.org/10.2337/db26-1373-p

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease